NeXstar regulatory update

NeXstar Pharmaceuticals Inc. (NXTR) NXTR's DaunoXome received approval in Sweden as a primary therapy for Kaposi's sarcoma. The liposomal formulation of daunorubicin will be sold by NXTR's partner, S...